Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibition of terfenadine metabolism. Pharmacokinetic and pharmacodynamic consequences.

× No keyword cloud information.

25 in total

1. Interaction between cyclosporine and fluconazole in renal allograft recipients.

Authors: D M Canafax; N M Graves; D M Hilligoss; B C Carleton; M J Gardner; A J Matas
Journal: Transplantation Date: 1991-05 Impact factor: 4.939

2. Torsades de Pointes after treatment with terfenadine and ketoconazole.

Authors: M Zimmermann; H Duruz; O Guinand; O Broccard; P Levy; D Lacatis; A Bloch
Journal: Eur Heart J Date: 1992-07 Impact factor: 29.983

3. Interaction of citrus juices with felodipine and nifedipine.

Authors: D G Bailey; J D Spence; C Munoz; J M Arnold
Journal: Lancet Date: 1991-02-02 Impact factor: 79.321

4. In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids.

Authors: F P Guengerich; D H Kim
Journal: Carcinogenesis Date: 1990-12 Impact factor: 4.944

5. Torsades de pointes occurring in association with terfenadine use.

Authors: D R Mathews; B McNutt; R Okerholm; M Flicker; G McBride
Journal: JAMA Date: 1991-11-06 Impact factor: 56.272

6. Dose of midazolam should be reduced during diltiazem and verapamil treatments.

Authors: J T Backman; K T Olkkola; K Aranko; J J Himberg; P J Neuvonen
Journal: Br J Clin Pharmacol Date: 1994-03 Impact factor: 4.335

7. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin.

Authors: P K Honig; R L Woosley; K Zamani; D P Conner; L R Cantilena
Journal: Clin Pharmacol Ther Date: 1992-09 Impact factor: 6.875

8. Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro.

Authors: D J Back; P Stevenson; J F Tjia
Journal: Br J Clin Pharmacol Date: 1989-08 Impact factor: 4.335

9. Mechanism of the cardiotoxic actions of terfenadine.

Authors: R L Woosley; Y Chen; J P Freiman; R A Gillis
Journal: JAMA Date: 1993 Mar 24-31 Impact factor: 56.272

10. The effect of fluconazole on the steady-state pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine in humans.

Authors: P K Honig; D C Worham; K Zamani; J C Mullin; D P Conner; L R Cantilena
Journal: Clin Pharmacol Ther Date: 1993-06 Impact factor: 6.875

16 in total

Review 1. Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin.

Authors: J F Westphal
Journal: Br J Clin Pharmacol Date: 2000-10 Impact factor: 4.335

Review 2. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors: K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal: Clin Pharmacokinet Date: 2000-02 Impact factor: 6.447

Review 3. Cytochrome P450s and other enzymes in drug metabolism and toxicity.

Authors: F Peter Guengerich
Journal: AAPS J Date: 2006-03-10 Impact factor: 4.009

Review 4. Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug.

Authors: Hongjian Zhang; Donghui Cui; Bonnie Wang; Yong-Hae Han; Praveen Balimane; Zheng Yang; Michael Sinz; A David Rodrigues
Journal: Clin Pharmacokinet Date: 2007 Impact factor: 6.447

Review 5. The influence of food on the absorption and metabolism of drugs: an update.

Authors: L Williams; D P Hill; J A Davis; D T Lowenthal
Journal: Eur J Drug Metab Pharmacokinet Date: 1996 Jul-Sep Impact factor: 2.441

6. Antibiotic exposure and its relationship to postantibiotic effect and bactericidal activity: constant versus exponentially decreasing tobramycin concentrations against Pseudomonas aeruginosa.

Authors: R C Li; Z Y Zhu; S W Lee; K Raymond; J M Ling; A F Cheng
Journal: Antimicrob Agents Chemother Date: 1997-08 Impact factor: 5.191

7. Hepatic disposition of fexofenadine: influence of the transport inhibitors erythromycin and dibromosulphothalein.

Authors: R W Milne; L A Larsen; K L Jørgensen; J Bastlund; G R Stretch; A M Evans
Journal: Pharm Res Date: 2000-12 Impact factor: 4.200

8. Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers.

Authors: S D Raeissi; I J Hidalgo; J Segura-Aguilar; P Artursson
Journal: Pharm Res Date: 1999-05 Impact factor: 4.200

Review 9. A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.

Authors: L L Carpenter; C J McDougle; C N Epperson; L H Price
Journal: Drug Saf Date: 1996-08 Impact factor: 5.606

Review 10. Pharmacokinetic-pharmacodynamic relationships of H1-antihistamines.

Authors: J P Desager; Y Horsmans
Journal: Clin Pharmacokinet Date: 1995-05 Impact factor: 6.447